Relationship between changes of electrocardiogram indexes in chronic heart failure with arrhythmia and serum PIIINP and BNP

Wang,Yue; Ma,Xiaoke

doi:10.3892/etm.2019.8269

Relationship between changes of electrocardiogram indexes in chronic heart failure with arrhythmia and serum PIIINP and BNP

Authors:
- Yue Wang
- Xiaoke Ma
View Affiliations

Affiliations: Electrocardiogram Room, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China, Departnent of Laboratory Medicine, Yantai Hospital of Traditional Chinese Medicine, Yantai, Shandong 264000, P.R. China
Published online on: December 2, 2019 https://doi.org/10.3892/etm.2019.8269
Pages: 591-596
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Relationship between changes of electrocardiogram (ECG) indexes in chronic heart failure (CHF) with arrhythmia and serum type III procollagen amino‑terminal peptide (PIIINP) and brain natriuretic peptide (BNP) were evaluated. From December 2017 to December 2018, 101 patients with heart failure (HF) were collected. Among them, 48 patients with HF and slow arrhythmia were in group A, and 53 cases of HF with non‑slow arrhythmia were sin group B, including 33 males and 20 females. BNP was detected by chemiluminescence and PIIINP was detected by immunoassay. The changes of ECG indexes in the two groups, the correlation between serum PIIINP and BNP and NYHA classification of cardiac function, and the correlation between ECG indexes and PIIINP and BNP were detected. ROC curve analysis of BNP and PIIINP in the diagnosis of slow HF was carried out. Serum PIIINP and BNP in group A were significantly higher than those in group B (P<0.05). The levels of PIIINP and BNP in serum of NYHA patients with different cardiac functions, and those in serum of patients with class III were significantly higher than those of group II (P<0.05), while significantly lower than those of group IV (P<0.05). The heart rate and Q‑T interval in group A were significantly higher than those in group B (P<0.05). The P‑R interval and QES wave group in group A were significantly lower than those in group B (P<0.05). BNP had a positive correlation with Hr and G‑T, and was negatively correlated with P‑R and QRS; PIIINP was positively correlated with Hr and G‑T, and had a negative correlation with P‑R, QRS and BNP; PIIINP had positive correlation with NYHA; ECG indexes were correlated with BNP and PIIINP, and had diagnostic value for CHF. Using ECG indexes to predict BNP and PIIINP levels was conducive to the diagnosis of CHF.

View Figures

View References

1	Morrissey RP, Czer L and Shah PK: Chronic heart failure. Wiley Handbook of Current and Emerging Drug Therapies. Am J Cardiovasc Drugs. 11:153–171. 2006. View Article : Google Scholar
2	Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, et al American College of Cardiology/American Heart Association, : ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 38:2101–2113. 2001. View Article : Google Scholar : PubMed/NCBI
3	Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, et al: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Updat). J Am Coll Cardiol. 46:1116–1143. 2005. View Article : Google Scholar
4	Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS and Granger CB: Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 27:65–75. 2006. View Article : Google Scholar : PubMed/NCBI
5	Hendry PB, Krisdinarti L and Erika M: Scoring system based on electrocardiogram features to predict the type of heart failure in patients with chronic heart failure. Cardiol Res. 7:110–116. 2016. View Article : Google Scholar : PubMed/NCBI
6	Petrovic D: Cytopathological basis of heart failure - cardiomyocyte apoptosis, interstitial fibrosis and inflammatory cell response. Folia Biol (Praha). 50:58–62. 2004.PubMed/NCBI
7	Lepojärvi ES, Piira OP, Pääkkö E, Lammentausta E, Risteli J, Miettinen JA, Perkiömäki JS, Huikuri HV and Junttila MJ: Serum PINP, PIIINP, galectin-3, and ST2 as surrogates of myocardial fibrosis and echocardiographic left venticular diastolic filling properties. Front Physiol. 6:2002015. View Article : Google Scholar : PubMed/NCBI
8	Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K and Yasue H: Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 87:1402–1412. 1991. View Article : Google Scholar : PubMed/NCBI
9	Anker SD, Coats AJ, Bonarjee VV, Caidahl K, Lie RT, Nilsen DW, Sundsfjord JA and Dickstein K: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation. 95:538–539. 1997.PubMed/NCBI
10	Nagaya N, Nishikimi T, Uematsu M, Satoh T, Kyotani S, Sakamaki F, Kakishita M, Fukushima K, Okano Y, Nakanishi N, et al: Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. J Cardiol. 37:110–111. 2001.(In Japanese). PubMed/NCBI
11	Degani R: Computerized electrocardiogram diagnosis: Fuzzy approach. Methods Inf Med. 31:225–233. 1992. View Article : Google Scholar : PubMed/NCBI
12	Nahler MPG: New York Heart Association classification (NYHA). Dictionary of Pharmaceutical Medicine. Springer; Vienna: pp. 121. 2009, View Article : Google Scholar
13	Wang Y, Xie B, Wan F, Xiao Q and Dai L: Application of ROC curve analysis in evaluating the performance of alien species potential distribution models. Biodiversity Sci. 15:365–372. 2007.(In Chinese). View Article : Google Scholar
14	Virk IS and Ip JR: The effect of cardiac resynchronization on morbidity and mortality in heart failure. Digest of the World Core Medical Journals 2005. https://doi.org/10.1111/j.1527-5299.2005.04176.xOctober 9–2008
15	Devereux RB and Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 55:613–618. 1977. View Article : Google Scholar : PubMed/NCBI
16	Droege ME, Mueller EW, Besl KM, Lemmink JA, Kramer EA, Athota KP, Droege CA, Ernst NE, Keegan SP, Lutomski DM, et al: Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients. J Trauma Acute Care Surg. 76:450–456. 2014. View Article : Google Scholar : PubMed/NCBI
17	Moe GW: BNP in the diagnosis and risk stratification of heart failure. Heart Fail Monit. 4:116–122. 2005.PubMed/NCBI
18	Aldamiz-Echevarría Iraúrgui B, Muñiz J, Rodríguez-Fernández JA, Vidán-Martínez L, Silva-César M, Lamelo-Alfonsín F, Díaz-Díaz JL, Ramos-Polledo V and Castro-Beiras A: Randomized controlled clinical trial of a home care unit intervention to reduce readmission and death rates in patients discharged from hospital following admission for heart failure. Rev Esp Cardiol. 60:914–922. 2007.(In Spanish). View Article : Google Scholar : PubMed/NCBI
19	Yonezawa E, Matsumoto K, Ueno K, Tachibana M, Hashimoto H, Komamura K, Kamakura S, Miyatake K and Tanaka K: Lack of interaction between amiodarone and mexiletine in cardiac arrhythmia patients. J Clin Pharmacol. 42:342–346. 2002. View Article : Google Scholar : PubMed/NCBI